Belumosudil (Rezurock,Beisudx)

Belumosudil Mesylate Tablets are a kinase inhibitor that exerts its therapeutic effect by inhibiting the activity of ROCK2 and ROCK1 to regulate immune responses and fibrotic signaling pathways.

200mg*30tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Belumosudil Drug News

Rezurock (belumosudil) Product Information - Price - Efficacy & Uses - Side Effects

On July 17, 2021, Kadmon Holdings announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock (belumosudil) 200 mg once daily (QD···【More】
Update: 01 Apr,2026Source: BigbearViews: 91
New Drug for Chronic Graft-versus-Host Disease (cGVHD)! FDA Approves First ROCK2 Inhibitor Rezurock

Kadmon Holdings recently announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock (belumosudil) 200 mg once daily (QD) for the···【More】
Update: 01 Apr,2026Source: BigbearViews: 93
REZUROCK has been included in the NCCN Guidelines

Chronic graft-versus-host disease (cGVHD) is a complication that can occur after allogeneic stem cell transplantation. The transplanted immune cells (···【More】
Update: 01 Apr,2026Source: BigbearViews: 90